NCT01765855View on ClinicalTrials.gov

An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Health Volunteers
Interventions
DRUG

Betrixaban single oral dose

Sponsors
All Listed Sponsors
lead

Portola Pharmaceuticals

INDUSTRY

NCT01765855 - An Open-Label, Single-Dose, Mass-Balance Study to Assess the Disposition of 14C-Labeled PRT054021 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter